AMAG Pharmaceuticals Inc. (AMAG) Stock Quote

Detailed Quote for AMAG Pharmaceuticals Inc. (AMAG)

After Hours: $ 15.85

0.00 (0.00%)

Volume: 231

4:50 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

December 27, 2011

Close: 19.62

52 Week Low

September 6, 2011

Close: 12.65

Today

Last Price
15.85

Change $
0.37

Change %
2.28%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
16.09

High
16.3079

Low
15.80

Prev Close
16.22

Last Trade
2/10/12

Volume
70.26 k

52 Wk Hi
19.62

52 Wk Low
12.65

Market Cap
336.07 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
21,202,959

EPS (TTM)
-3.69

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for AMAG Pharmaceuticals Inc. (AMAG)

Sector News | Topic News

News for AMAG

Fri, Feb 10, 2012

9:00 AM

A Forward Look, The Year Ahead - Featured Research on AMAG Pharmaceuticals, Inc. and Akorn, Inc. - Marketwire

Tue, Feb 07, 2012

4:30 PM

AMAG Pharmaceuticals Announces the Appointment of Two Independent Directors to its Board - Business Wire

Mon, Jan 30, 2012

8:30 AM

AMAG Pharmaceuticals Announces Completion of Enrollment in its Phase III Program Evaluating Feraheme for a Broader Iron Deficiency Anemia Indication - Business Wire

Mon, Jan 09, 2012

7:30 AM

AMAG Pharmaceuticals Provides Business Update - Business Wire

Wed, Jan 04, 2012

7:30 AM

AMAG Pharmaceuticals, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire

Mon, Dec 12, 2011

7:45 AM

Health Canada Approves Feraheme® (ferumoxytol) to Treat Iron Deficiency Anemia in Adults with Chronic Kidney Disease - Business Wire

7:42 AM

AMAG Pharmaceuticals Announces Preliminary Data Regarding the Safety and Efficacy of a Single Infusion of 1020 mg Ferumoxytol (Feraheme®) in Patients with Iron Deficiency Anemia - Business Wire

Tue, Nov 22, 2011

4:30 PM

AMAG Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Healthcare Conference - Business Wire

Thu, Nov 17, 2011

8:30 AM

AMAG Pharmaceuticals Hires Financial Advisor as the Company Explores All Opportunities to Enhance Stockholder Value - Business Wire

Mon, Nov 07, 2011

9:01 AM

Professional Outlook, Will EU's Deal Hold the Markets? - Equity Research on AMAG Pharmaceuticals, Inc. and Hologic, Inc. - Marketwire

Fri, Oct 29, 2010

5:05 PM

Wall Street Ends Day Flat; Month Strong - WALLSTmoney

1:00 PM

Stocks Flat on Wall Street - WALLSTmoney

11:05 AM

Mixed Data Keeps Stocks on Wall Street Flat - WALLSTmoney

More News for AMAG >>

Tags for AMAG Pharmaceuticals Inc.

Research stocks or mutual funds related to AMAG Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to AMAG. The keywords below have been associated to AMAG by either user submission or electronic means.

schering plough health care products biotechnology company pharmaceuticals research pharmaceuticals international research pharmaceutical branding pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics pharmaceuticals careers europe pharmaceuticals advanced magnetics pharmaceutical research and development dupont pharmaceuticals pharma marketing pharmaceutical industry marketing pharmaceuticals germany pharmaceutical software pharma manufacturing pharma license pharmaceuticals supply chain generic products pharmaceutical cro pharma companies pharmaceutical sales pharma consultants pharma top selling products mckesson products pharmaceutical reports pharmaceutical consultant biotech Drugs massengill products pharma r&d pharmaceutical manufacturing software pharmaceutical conference pharmaceutical manufacturing amag contract pharmaceutical pharmaceutical consulting pharmaceutical industry par pharmaceutical pharmaceutical studies pharmaceutical advances online pharmaceutical pharmaceutical out licensing merck pharmaceuticals pharmaceutical business development Healthcare